Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 7, 2007, Pages 403-408

  Rigato, Igino ^a   Cravatari, Monica ^b   Avellini, Claudio ^c   Ponte, Euro ^b   Crocè, Saveria Lory ^b   Tiribelli, Claudio ^b  

^a Liver Research Center   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETIZOLAM; FLAVOXATE; GLUCURONOSYLTRANSFERASE 1A1; TIBOLONE; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE; PREGNANE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLANGIOGRAPHY; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DRUG WITHDRAWAL; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GILBERT DISEASE; HEPATITIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INSOMNIA; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MENOPAUSAL SYNDROME; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY; SIDE EFFECT; TREATMENT DURATION; URINE INCONTINENCE; CLIMACTERIUM; FOLLOW UP; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PATHOLOGY; RISK ASSESSMENT; TOXIC HEPATITIS;

ACUTE DISEASE; CLIMACTERIC; FEMALE; FLAVOXATE; FOLLOW-UP STUDIES; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HEPATITIS, TOXIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TESTS; MIDDLE AGED; MUTATION; NORPREGNENES; RISK ASSESSMENT; URINARY INCONTINENCE;

EID: 34447618602     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0871     Document Type: Article

References (18)

1. Sgro C et al. (2002) Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 36: 451-455.
2. Zimmerman HJ and Ishak KG (2003) Hepatic injury due to drugs and toxins. In Pathology of the liver, 621-709 (Eds MacSween RNM et al.) London, UK: Churchill Livingstone
3. Kenemans P and Speroff L (2005) Tibolone: Clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group, Maturitas 51: 21-28
4. Egarter C et al. (1999) Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women. Int J Gynaecol Obstet 64: 281-286
5. Blanco Sampascual S et al. (2002) Tibolone-induced hepatotoxicity. Gastroenterol Hepatol 25: 274
6. Guay DR (2003) Clinical pharmacokinetics of drugs used to treat urge incontinence. Clin Pharmacokinet 42: 1243-1285
7. Wang PS et al. (2002) Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc 50: 117-124
8. Sevenoaks M and Gorard DA (1999) Jaundice associated with flavoxate. J R Soc Med 92: 589
9. Navarro VJ and Senior JR (2006) Drug-related hepatotoxicity. N Engl J Med 354: 731-739
10. Danan G and Benichou C (1993) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 46: 1323-1330
11. Burchell B et al. (2000) Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferas es. Toxicol Lett 112-113: 333-340
12. Bosma PJ (2003) Inherited disorders of bilirubin metabolism. J Hapatol 38: 107-117
13. Gentile S et al. (1985) Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: Evidence of a functional heterogeneity. Hepatogastroenterology 32: 113-116
14. Carulli N et al. (1976) Alteration of drug metabolism in Gilbert's syndrome. Gut 17: 581-587
15. Senafi SB et al. (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303: 233-240
16. Wasserman E et al. (1997) Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports. Ann Oncol 8: 1049-1051
17. Monaghan G et al. (1996) Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347: 578-581
18. Fevery J et al. (1997) Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 60 970-979